| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RAPT Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $57.72 | 03 Mar 2026 | Direct |
| Epizyme, Inc. | Director | Common Stock, par value $0.0001 | 0 | $1.41 | 12 Aug 2022 | Direct | |
| RAPT Therapeutics, Inc. | Director | Director Stock Option (right to buy) | 0 | 03 Mar 2026 | Direct |